Benefits
Highest GLA Concentration of Plant Oils
Distinguishes borage from evening primrose (~9% GLA) and black currant (~15% GLA). Lower volume of borage oil needed for equivalent GLA dose. Cost-effective GLA source per dose.
Rheumatoid Arthritis Adjunct
Multiple trials (others) show GLA from borage oil (1.4 g/day) reduces joint pain, morning stiffness, and NSAID requirements in RA. Adjunct to standard treatment. Effect smaller than fish oil EPA/DHA but documented.
Atopic Dermatitis / Eczema (Mixed Evidence)
Earlier trials suggested benefit; larger systematic review of 27 trials found GLA (from borage and evening primrose) NOT effective for atopic dermatitis. Current consensus: limited/no benefit despite long-standing folk use.
Premenstrual Syndrome Support
Some evidence for cyclic mastalgia and PMS symptoms. Effects modest; foundational evidence from older trials less robust by modern standards.
Diabetic Neuropathy Adjunct
Older research suggested GLA may help diabetic neuropathy. Modern evidence less robust; alpha-lipoic acid has stronger evidence for this indication.
Mechanism of action
GLA → DGLA → PGE1 Anti-Inflammatory Pathway
GLA (gamma-linolenic acid) is metabolized via elongase to DGLA (dihomo-gamma-linolenic acid), which produces SERIES-1 PROSTAGLANDINS (PGE1) — anti-inflammatory, anti-platelet, vasodilatory. Distinguishes from arachidonic acid pathway producing pro-inflammatory PGE2. Mechanism for anti-inflammatory effects.
Bypass Delta-6 Desaturase Limitation
Conversion of LA to GLA requires DELTA-6 DESATURASE — limited in: aging, diabetes, alcohol use, deficiency states. Direct GLA supplementation bypasses this conversion bottleneck. Theoretical advantage in those with reduced conversion capacity.
Skin Barrier Lipid Support
GLA contributes to skin barrier lipid composition; theoretical benefit for skin conditions (though clinical evidence limited for eczema).
Cytokine Modulation
GLA modulates pro-inflammatory cytokine production (TNF-α, IL-1β, IL-6) via DGLA-derived eicosanoids and direct effects.
Clinical trials
RCT of borage oil GLA (1.4 g GLA/day) vs placebo in 37 RA patients for 24 weeks.
37 RA patients.
GLA group had significant improvements in joint tenderness, swelling, and morning stiffness. Established borage oil as RA adjunct. Adjunct only — not replacement for DMARDs/biologics.
Systematic review/meta-analysis of 27 RCTs of borage and evening primrose oil for atopic dermatitis.
Pooled across 27 RCTs.
GLA NOT effective for atopic dermatitis. Despite long folk use, RCT evidence does not support benefit. Notable example of folk medicine claims not surviving rigorous evaluation.